• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向肾脏进展的统一理论。

Toward a unified theory of renal progression.

作者信息

Harris Raymond C, Neilson Eric G

机构信息

Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

出版信息

Annu Rev Med. 2006;57:365-80. doi: 10.1146/annurev.med.57.121304.131342.

DOI:10.1146/annurev.med.57.121304.131342
PMID:16409155
Abstract

Various disciplines within nephrology investigate the mechanisms by which kidneys fail. Progress in the areas of glomerular hemodynamics, proteinuria, tubular biology, interstitial nephritis, fibroblast formation, and fibrosis have added kernels of information that together support a unified theory of renal progression. Prevention of progression to end-stage disease has largely focused on control of systemic and glomerular hypertension. Current success in delaying a decline in glomerular filtration rate underlines the promise of a more comprehensive approach. New knowledge about the cell biology of progression also suggests that other adjunctive therapies may be possible. We describe the progress and highlight those spheres where new-targeted interventions may arise.

摘要

肾脏病学的各个学科都在研究肾脏衰竭的机制。肾小球血流动力学、蛋白尿、肾小管生物学、间质性肾炎、成纤维细胞形成和纤维化等领域的进展提供了一些信息要点,共同支持了一个关于肾脏病变进展的统一理论。预防疾病进展至终末期主要集中在控制全身性和肾小球性高血压。目前在延缓肾小球滤过率下降方面取得的成功凸显了采用更全面方法的前景。关于病变进展的细胞生物学的新知识也表明可能有其他辅助治疗方法。我们描述了这方面的进展,并着重指出可能出现新的靶向干预措施的领域。

相似文献

1
Toward a unified theory of renal progression.迈向肾脏进展的统一理论。
Annu Rev Med. 2006;57:365-80. doi: 10.1146/annurev.med.57.121304.131342.
2
[The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].[肾小管间质改变在慢性肾小球肾炎(GN)患者肾功能衰竭进展中的作用]
Przegl Lek. 1996;53(5):443-53.
3
Progression to renal failure.进展至肾衰竭。
Turk J Pediatr. 2005;47 Suppl:3-8.
4
Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.免疫球蛋白A肾病的自然病程及预后预测因素:中国204例患者的长期随访
Nephrology (Carlton). 2008 Jun;13(3):242-6. doi: 10.1111/j.1440-1797.2007.00898.x. Epub 2008 Jan 23.
5
[Mechanism of progression of chronic renal failure and new treatment strategies].[慢性肾衰竭的进展机制与新治疗策略]
Pol Merkur Lekarski. 2000 Apr;8(46):301-2.
6
Renal protection: progression, regression, remission from nephropathy beyond blood pressure control.肾脏保护:超越血压控制的肾病进展、逆转与缓解。
Int J Clin Pract Suppl. 2000 May(110):9-15.
7
Mechanisms of progression of chronic renal damage.慢性肾损伤的进展机制。
J Nephrol. 1999 Jul-Aug;12 Suppl 2:S53-62.
8
Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy.饮食蛋白质/热量摄入对5/6肾切除猫肾脏形态和功能的影响。
Lab Invest. 1994 Mar;70(3):347-57.
9
Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.卡维地洛对阿霉素肾病自发性高血压大鼠脉压及左心室肥厚的影响。
Biomed Pharmacother. 2009 Sep;63(8):571-6. doi: 10.1016/j.biopha.2008.10.006. Epub 2008 Oct 31.
10
Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.在糖尿病肾病中,肾功能下降与蛋白尿及早晨收缩压相关。
Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.

引用本文的文献

1
Administration of Purified Alpha-1 Antitrypsin in Salt-Loaded Hypertensive 129Sv Mice Attenuates the Expression of Inflammatory Associated Proteins in the Kidney.给盐负荷高血压129Sv小鼠注射纯化的α-1抗胰蛋白酶可减轻肾脏中炎症相关蛋白的表达。
Biomolecules. 2025 Jun 30;15(7):951. doi: 10.3390/biom15070951.
2
Extracellular Vesicles in Renal Inflammatory Diseases: Revealing Mechanisms of Extracellular Vesicle-Mediated Macrophage Regulation.肾脏炎症性疾病中的细胞外囊泡:揭示细胞外囊泡介导的巨噬细胞调节机制
Int J Mol Sci. 2025 Apr 12;26(8):3646. doi: 10.3390/ijms26083646.
3
MiR-92a-3p Promotes Renal Injury and Fibrosis Through Facilitating M1 Macrophage Polarization via Targeting LIN28A.
miR-92a-3p 通过靶向 LIN28A 促进 M1 巨噬细胞极化从而促进肾损伤和纤维化。
Physiol Res. 2024 Nov 15;73(5):755-767. doi: 10.33549/physiolres.935305.
4
Renal Inflammation, Oxidative Stress, and Metabolic Abnormalities During the Initial Stages of Hypertension in Spontaneously Hypertensive Rats.自发性高血压大鼠高血压初期的肾脏炎症、氧化应激和代谢异常。
Cells. 2024 Oct 25;13(21):1771. doi: 10.3390/cells13211771.
5
ELABELA-derived peptide ELA13 attenuates kidney fibrosis by inhibiting the Smad and ERK signaling pathways.ELABELA 衍生肽 ELA13 通过抑制 Smad 和 ERK 信号通路来减轻肾脏纤维化。
J Zhejiang Univ Sci B. 2024 Apr 15;25(4):341-353. doi: 10.1631/jzus.B2300033.
6
Validation of the Kidney Failure Risk Equation in the Colombian Population.肾衰竭风险方程在哥伦比亚人群中的验证。
Int J Nephrol. 2024 Feb 17;2024:1282664. doi: 10.1155/2024/1282664. eCollection 2024.
7
HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy.HCK 通过抑制自噬诱导巨噬细胞活化,促进肾脏炎症和纤维化。
Nat Commun. 2023 Jul 18;14(1):4297. doi: 10.1038/s41467-023-40086-3.
8
Efficacy and safety of activating blood circulation and removing blood stasis of Traditional Chinese Medicine for managing renal fibrosis in patients with chronic kidney disease: a systematic review and Meta-analysis.活血化瘀中药治疗慢性肾脏病肾纤维化患者的疗效及安全性的系统评价和 Meta 分析。
J Tradit Chin Med. 2023 Jun;43(3):429-440. doi: 10.19852/j.cnki.jtcm.20230308.003.
9
Urinary Dickkopf-3 (DKK3) Is Associated with Greater eGFR Loss in Patients with Resistant Hypertension.尿Dickkopf-3(DKK3)与顽固性高血压患者更大的估算肾小球滤过率(eGFR)下降相关。
J Clin Med. 2023 Jan 29;12(3):1034. doi: 10.3390/jcm12031034.
10
Emergence of New Immunopathogenic Factors in Human Yellow Fever: Polarisation of the M1/M2 Macrophage Response in the Renal Parenchyma.人类黄热病中新免疫发病因子的出现:肾实质中 M1/M2 巨噬细胞反应的极化。
Viruses. 2022 Aug 4;14(8):1725. doi: 10.3390/v14081725.